Description

Citurgia Biochemicals Ltd. equity shares will be moved to 'B' group effective February 17, 2026.

Summary

BSE has announced that the equity shares of Citurgia Biochemicals Ltd. (Scrip Code: 506373) will be included under ‘B’ group effective February 17, 2026. This represents a change in the trading group classification for the company’s equity shares.

Key Points

  • Company affected: Citurgia Biochemicals Ltd.
  • Scrip Code: 506373
  • New group classification: ‘B’ group
  • Effective date: February 17, 2026
  • Contact for clarification: Mrs. Kinjal More, Cell: +91-7304278788

Regulatory Changes

The equity shares of Citurgia Biochemicals Ltd. will be reclassified from their current group to ‘B’ group. The ‘B’ group typically represents companies that meet certain criteria related to trading volume, market capitalization, or corporate governance standards as per BSE’s classification framework.

Compliance Requirements

Trading members must:

  • Note the group change for Scrip Code 506373
  • Update their systems and records to reflect the new ‘B’ group classification
  • Ensure all trading activities from February 17, 2026 onwards treat this scrip under ‘B’ group parameters
  • Contact Mrs. Kinjal More for any clarifications regarding this change

Important Dates

  • Notice Date: February 10, 2026
  • Effective Date: February 17, 2026

Impact Assessment

The reclassification to ‘B’ group may affect:

  • Trading parameters and margin requirements for the scrip
  • Investor perception and liquidity characteristics
  • Settlement and risk management procedures
  • Market surveillance measures applicable to the scrip

Trading members should ensure their systems are updated before the effective date to maintain smooth trading operations.

Impact Justification

Group reclassification affects trading parameters and investor perception but is limited to a single scrip with specific effective date